Factors Associated with Influenza Vaccination of Hospitalized Elderly Patients in Spain

PLoS One. 2016 Jan 29;11(1):e0147931. doi: 10.1371/journal.pone.0147931. eCollection 2016.

Abstract

Vaccination of the elderly is an important factor in limiting the impact of influenza in the community. The aim of this study was to investigate the factors associated with influenza vaccination coverage in hospitalized patients aged ≥ 65 years hospitalized due to causes unrelated to influenza in Spain. We carried out a cross-sectional study. Bivariate analysis was performed comparing vaccinated and unvaccinated patients, taking in to account sociodemographic variables and medical risk conditions. Multivariate analysis was performed using multilevel regression models. We included 1038 patients: 602 (58%) had received the influenza vaccine in the 2013-14 season. Three or more general practitioner visits (OR = 1.61; 95% CI 1.19-2.18); influenza vaccination in any of the 3 previous seasons (OR = 13.57; 95% CI 9.45-19.48); and 23-valent pneumococcal polysaccharide vaccination (OR = 1.97; 95% CI 1.38-2.80) were associated with receiving the influenza vaccine. Vaccination coverage of hospitalized elderly people is low in Spain and some predisposing characteristics influence vaccination coverage. Healthcare workers should take these characteristics into account and be encouraged to proactively propose influenza vaccination to all patients aged ≥ 65 years.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Cross-Sectional Studies
  • Female
  • Humans
  • Influenza A virus / immunology
  • Influenza Vaccines / administration & dosage*
  • Influenza, Human / immunology
  • Influenza, Human / prevention & control*
  • Influenza, Human / virology
  • Inpatients / psychology
  • Male
  • Marital Status / statistics & numerical data
  • Patient Education as Topic
  • Pneumococcal Vaccines / administration & dosage*
  • Pneumonia, Pneumococcal / immunology
  • Pneumonia, Pneumococcal / microbiology
  • Pneumonia, Pneumococcal / prevention & control*
  • Social Class
  • Spain
  • Streptococcus pneumoniae / immunology
  • Vaccination / psychology
  • Vaccination / statistics & numerical data*

Substances

  • Influenza Vaccines
  • Pneumococcal Vaccines

Grants and funding

This study was funded by the National Plan of I+D+I 2008-2011 and ISCIII-Subdirección General de Evaluación y Fomento de la Investigación (Project PI12/02079) and cofounded by Fondo Europeo de Desarrollo Regional (FEDER. Unión Europea. Una manera de hacer Europa), and the Catalan Agency for the Management of Grants for University Research (AGAUR Grant number 2014/ SGR 1403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.